The study also demonstrated that AHCTF1 heterozygosity, in combination with reduced expression of another NUP gene, RANBP2, or treatment with the nucleocytoplasmic transport inhibitor Selinexor, effectively blocked KRAS-driven hepatocyte hyperplasia in zebrafish models of HCC. The gene discussed is RANBP2; the disease is hepatocellular carcinoma.